The TCF4 Trinucleotide Repeat Expansion of Fuchs’ Endothelial Corneal Dystrophy: Implications for the Anterior Segment of the Eye
Investigative Opthalmology & Visual Science · 19.05.2023 · 64 (5) · 16
DOI: 10.1167/iovs.64.5.16 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Opthalmology & Visual Science, erschienen am 19.05.2023. Verfasst von Jiaxin Hu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas, United States. Hauptthemen laut MEDLINE: Trinucleotide Repeat Expansion, Fuchs' Endothelial Dystrophy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NEI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Purpose
In the United States, 70% of Fuchs' endothelial corneal dystrophy (FECD) cases are caused by an intronic trinucleotide repeat expansion in the TCF4 gene. CUG repeat RNA transcripts from this expansion accumulate as nuclear foci in the corneal endothelium. In this study, we sought to detect foci in other anterior segment cell types and assess their molecular impact.
Methods
We examined CUG repeat RNA foci appearance, expression of downstream affected genes, gene splicing, and TCF4 RNA expression in corneal endothelium, corneal stromal keratocytes, corneal epithelium, trabecular meshwork cells, and lens epithelium.
Results
CUG repeat RNA foci, the hallmark of FECD in corneal endothelium (found in 84% of endothelial cells), are less detectable in trabecular meshwork cells (41%), much less prevalent in stromal keratocytes (11%) or corneal epithelium (4%), and absent in lens epithelium. With few exceptions including mis-splicing in the trabecular meshwork, differential gene expression and splicing changes associated with the expanded repeat in corneal endothelial cells are not observed in other cell types. Expression of the TCF4 transcripts including full-length isoforms containing the repeat sequence at the 5' end is much higher in the corneal endothelium or trabecular meshwork than in the corneal stroma or corneal epithelium.
Conclusions
Expression of the CUG repeat containing TCF4 transcripts is higher in the corneal endothelium, likely contributing to foci formation and the large molecular and pathologic impact on those cells. Further studies are warranted to examine any glaucoma risk and impact of the observed foci in the trabecular meshwork of these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas, United States.
- Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas, United States.
- Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, Texas, United States.
- Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, Texas, United States.
Förderung
- NEI NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Hu, J., Gong, X., Johnson, S. T., Corey, D. R., & Mootha, V. V. (2023). The TCF4 Trinucleotide Repeat Expansion of Fuchs’ Endothelial Corneal Dystrophy: Implications for the Anterior Segment of the Eye. Investigative Opthalmology & Visual Science, 64(5), 16. https://doi.org/10.1167/iovs.64.5.16
Vancouver
Hu J, Gong X, Johnson ST, Corey DR, Mootha VV. The TCF4 Trinucleotide Repeat Expansion of Fuchs’ Endothelial Corneal Dystrophy: Implications for the Anterior Segment of the Eye. Investigative Opthalmology & Visual Science. 2023;64(5):16. doi:10.1167/iovs.64.5.16
BibTeX
@article{Hu2023,
author = {Hu, Jiaxin and Gong, Xin and Johnson, Samantha T and Corey, David R and Mootha, V Vinod},
title = {The TCF4 Trinucleotide Repeat Expansion of Fuchs’ Endothelial Corneal Dystrophy: Implications for the Anterior Segment of the Eye},
journal = {Investigative Opthalmology & Visual Science},
year = {2023},
volume = {64},
number = {5},
pages = {16},
doi = {10.1167/iovs.64.5.16}
}
EUVIMED